Pfizer is looking to expand its role in the generics market, reports the Health Blog at the Wall Street Journal. To grow in this market, the president of Pfizer's established products business says they will "develop its own new products, buy licenses or acquire companies." Simmons did not say whether Pfizer was looking into acquiring the Icelandic Actavis Group or the German Ratiopharm, which are both on the market.